provid
care
patient
frequent
perform
procedur
gener
aerosol
eg
endotrach
intub
open
suction
nebul
treatment
anesthesiologist
intensivist
especi
risk
expos
novel
coronaviru
put
high
risk
infect
demonstr
recent
public
show
health
care
worker
higher
infect
rate
compar
normal
addit
given
anesthesiologist
intensivist
care
patient
basic
knowledg
cours
effect
treat
patient
optim
protect
cov
found
global
human
mani
differ
anim
speci
classifi
orthocoronavirida
subfamili
order
nidoviral
subordin
cornidovirinea
famili
coronavirida
cov
group
includ
infect
mammal
primarili
infect
bird
cov
envelop
virus
lipid
membran
deriv
host
cell
viral
surfac
protein
embed
protein
protrud
viral
membran
especi
spike
protein
give
pathogen
characterist
halolik
appear
electron
microscop
led
name
corona
latin
garland
crown
cov
common
genom
form
singlestrand
ribonucl
acid
rna
posit
polar
mean
base
sequenc
rna
orient
correspond
later
messeng
rna
mrna
length
kilobas
genom
cov
largest
rna
genom
known
rna
besid
number
nonstructur
protein
includ
rnadepend
rna
polymeras
rdrp
viral
rna
encod
structur
protein
name
nucleocapsid
n
protein
surround
rna
genom
protein
sglycoprotein
matrix
protein
envelop
e
sglycoprotein
surfac
cov
attach
cellular
receptor
angiotensinconvert
enzym
surfac
human
found
lower
respiratori
tract
human
regul
crossspeci
humantohuman
cov
high
mutat
rate
due
errorpron
rdrp
respons
duplic
genet
addit
homolog
recombin
often
occur
properti
contribut
great
divers
cov
natur
enabl
virus
infect
numer
speci
first
coronaviru
describ
isol
chicken
embryo
infecti
bronchiti
viru
ibv
sinc
numer
cov
detect
wide
varieti
anim
includ
wild
anim
farm
anim
pet
divid
genera
mammalianassoci
birdassoci
variou
cov
import
veterinari
medicin
transmiss
gastroenter
coronaviru
tgev
porcin
epidem
diarrhea
viru
pedv
caus
sever
diarrhea
pig
spectrum
coronaviru
diseas
anim
rang
mild
sever
intestin
respiratori
system
howev
also
mani
coronaviru
infect
anim
appear
caus
symptom
presenc
cov
wide
varieti
anim
speci
strongli
suggest
pathogen
zoonot
origin
transmit
wild
anim
human
particular
sar
pandem
led
increas
number
studi
wild
anim
contin
greatest
divers
cov
far
detect
led
hypothesi
least
recent
cov
introduct
human
origin
bat
virus
spread
intermedi
anim
eg
himalayan
palm
civet
sarscov
dromedari
camel
middl
east
respiratori
syndrom
mer
cov
expos
human
virus
howev
assum
still
gap
detect
zoonot
cov
wild
anim
popul
particular
data
situat
econom
andor
polit
unstabl
region
world
still
first
human
coronavirus
hcov
describ
design
hcov
known
circul
worldwid
human
popul
case
endem
hcov
caus
rel
mild
diseas
upper
lower
respiratori
tract
estim
account
third
common
cold
human
asymptomat
infect
also
describ
case
especi
immunosuppress
individu
children
person
exist
pulmonari
diseas
progress
acut
respiratori
failur
also
situat
complet
chang
appear
viru
caus
seriou
human
respiratori
diseas
china
approxim
peopl
affect
diseas
time
case
fatal
rate
mortal
rate
around
sarscov
spread
could
stop
rapid
develop
detect
method
extens
measur
isol
infect
individu
subsequ
studi
wild
anim
show
sarsrel
cov
found
bat
civet
cat
henc
assum
viru
spread
civet
cat
human
follow
humantohuman
human
infect
origin
sar
viru
report
sinc
anoth
cov
danger
human
emerg
merscov
isol
first
time
patient
hospit
acut
pneumonia
saudi
around
merscov
infect
report
human
case
fatal
main
risk
area
merscov
infect
arabian
peninsula
infect
report
humantohuman
transmiss
contact
dromedari
camel
anim
appear
repres
reservoir
end
decemb
china
report
increas
occurr
pneumonia
citi
wuhan
hubei
provinc
januari
novel
identifi
viru
first
isol
pneumonia
case
wuhan
china
decemb
name
novel
coronaviru
inform
genet
analys
becam
avail
viru
given
offici
name
intern
committe
taxonomi
virus
name
diseas
caus
viru
genom
new
coronaviru
show
similar
found
ident
bat
cov
wherea
share
ident
sarscov
therefor
assum
viru
origin
came
bat
transmit
time
anim
host
ultim
human
although
degre
diversif
lower
exampl
influenza
virus
diverg
evolv
type
l
type
type
accord
studi
strain
l
type
deriv
type
evolutionarili
aggress
contagi
clear
also
use
cellular
receptor
infect
effici
transmit
persontoperson
thu
abl
spread
rapidli
across
contin
global
world
result
pandem
peopl
infect
patient
die
far
march
sourc
john
hopkin
univers
emerg
acut
respiratori
infecti
diseas
primarili
spread
respiratori
tract
droplet
respiratori
secret
direct
addit
report
isol
fecal
swab
indic
possibl
multipl
rout
transmiss
howev
need
clarif
current
data
suggest
incub
period
day
case
day
viru
highli
transmiss
human
caus
sever
problem
especi
elderli
peopl
underli
chronic
diseas
patient
typic
present
specif
similar
symptom
fever
malais
adult
children
infect
present
mild
flulik
symptom
patient
critic
condit
rapidli
develop
acut
respiratori
distress
syndrom
ard
respiratori
failur
multipl
organ
failur
even
accord
recent
report
common
clinic
manifest
includ
fever
cough
fatigu
sputum
product
short
breath
sore
throat
headach
minor
number
patient
manifest
gastrointestin
symptom
diarrhea
vomit
fever
cough
domin
symptom
wherea
upper
respiratori
symptom
gastrointestin
symptom
rare
case
fatal
rate
increas
sever
ill
reach
critic
ill
unfortun
specif
therapeut
option
current
avail
support
measur
appli
specif
antivir
treatment
recommend
vaccin
current
avail
sever
worldwid
effort
develop
vaccin
howev
alreadi
clear
vaccin
strategi
avail
earliest
thu
help
immedi
countermeasur
thu
antivir
drug
urgent
need
new
drug
licens
well
repurpos
indic
drug
alreadi
clinic
use
diseas
would
promis
option
short
term
sever
drug
candid
propos
test
includ
human
immunodefici
viru
hiv
drug
lopinavirritonavir
antimalari
drug
chloroquin
hydroxychloroquin
remdesivir
inhibitor
rna
polymeras
vitro
activ
multipl
rna
virus
includ
ebola
howev
result
mani
initi
trial
suffer
small
sampl
size
andor
nonrigor
studi
design
lopinavirritonavir
test
rigor
random
control
openlabel
trial
involv
hospit
adult
patient
confirm
infect
benefit
observ
beyond
standard
recent
trial
use
hydroxychloroquin
promis
show
treatment
significantli
associ
viral
load
reductiondisappear
studi
includ
small
number
individu
therefor
consid
limit
valid
preclin
studi
suggest
remdesivir
could
effect
prophylaxi
therapi
hcov
drug
posit
test
rhesu
macaqu
model
merscov
report
treat
first
case
unit
state
accordingli
clinic
trial
mildmoder
sever
initi
china
estim
end
date
earli
april
similarli
current
lack
valid
rigor
clinic
studi
prompt
mani
clinic
trial
around
world
one
exampl
europ
begun
larg
joint
clinic
studi
experiment
drug
treat
trial
includ
patient
netherland
belgium
luxembourg
unit
kingdom
franc
spain
test
clinic
efficaci
antivir
drug
remdesivir
lopinavirritonavir
hydroxychloroquin
name
stephan
ludwig
phd
contribut
author
help
write
revis
manuscript
name
alexand
zarbock
md
contribut
author
help
write
revis
manuscript
manuscript
handl
thoma
r
vetter
md
mph
